Head-to-head · WeighScore
EdgeRx vs WeightRx
By GLP-1 ScorecardUpdated
Score comparison
EdgeRx has the higher recorded score — 79/100 to 72.1/100.
EdgeRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. EdgeRx lists compounded GLP-1 injections in a men’s health program. Its terms say the final charge can vary with the prescription and pharmacy.
Before you choose
Before comparing the headline prices, the EdgeRx review and the WeightRx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, EdgeRx vs WePeptideRx and Elara MD vs WeightRx compare each of them with another graded program, and the list of alternatives to EdgeRx ranks the programs closest to EdgeRx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | EdgeRx | WeightRx |
|---|---|---|
| WeighScore | 79/100 | 72.1/100 |
| Grade | C+ | C |
| Site position | #42 | #93 |
| Semaglutide | Advertised $199/mo; confirm final prescription charge | $250/mo (advertised; selected term and charge unverified) |
| Tirzepatide | Advertised $225/mo; confirm final prescription charge | From $83/mo (compounded; selected term and charge unverified) |
| Coverage | 47 states advertised; excludes Arkansas, Indiana and South Carolina | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Publishes separate semaglutide and tirzepatide prices
- Names Strive as its primary 503A pharmacy in its terms
- Advertises included shipping and physician review
What to consider
- The final charge may vary with the prescribed product and dispensing pharmacy
- The homepage’s approval refund language needs to be reconciled with the consultation fee and final-sale terms
Strengths
- Advertises bundled medication, care and shipping
- Publishes a cancellation and refund policy
What to consider
- The public treatment cards leave the selected debit and supply unclear
- The refund policy says six- and twelve-month plans are nonrefundable
- Named brand treatment cards are marked coming soon
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.